Title
Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians
Date Issued
01 December 2019
Access level
open access
Resource Type
journal article
Author(s)
Luo Y.
Suliman S.
Asgari S.
Amariuta T.
Baglaenko Y.
Martínez-Bonet M.
Ishigaki K.
Gutierrez-Arcelus M.
León S.R.
Contreras C.
Galea J.T.
Becerra M.
Nejentsev S.
Nigrovic P.A.
Moody D.B.
Murray M.B.
Raychaudhuri S.
Publisher(s)
Nature Publishing Group
Abstract
Of the 1.8 billion people worldwide infected with Mycobacterium tuberculosis, 5–15% will develop active tuberculosis (TB). Approximately half will progress to active TB within the first 18 months after infection, presumably because they fail to mount an effective initial immune response. Here, in a genome-wide genetic study of early TB progression, we genotype 4002 active TB cases and their household contacts in Peru. We quantify genetic heritability (hg2) of early TB progression to be 21.2% (standard error 0.08). This suggests TB progression has a strong genetic basis, and is comparable to traits with well-established genetic bases. We identify a novel association between early TB progression and variants located in a putative enhancer region on chromosome 3q23 (rs73226617, OR = 1.18; P = 3.93 × 10−8). With in silico and in vitro analyses we identify rs73226617 or rs148722713 as the likely functional variant and ATP1B3 as a potential causal target gene with monocyte specific function.
Volume
10
Issue
1
Language
English
OCDE Knowledge area
Sistema respiratorio Enfermedades infecciosas Genética humana
Scopus EID
2-s2.0-85071073400
PubMed ID
Source
Nature Communications
ISSN of the container
20411723
Sponsor(s)
The study was supported by the National Institutes of Health (NIH) TB Research Unit Network, Grant U19 AI111224 and NHGRI U01 HG009379. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. S.N. was supported by MRC (MR/M012328/1), the ERC Starting grant (260477) and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. T.A. was supported by NIH (NHGRI T32 HG002295). The authors thank Garðar Sveinbjornsson, Patrick Sulem, Ingileif Jonsdottir, and Kari Stefansson at deCODE genetics, Reykjavik, Iceland, for validating the association of rs73226617 with TB progression in the Icelandic population.
Sources of information: Directorio de Producción Científica Scopus